Maccura Biotechnology Co.Ltd (SHE:300463)
China · Delayed Price · Currency is CNY 10.28
+0.02 (0.19%)
May 19, 2026, 10:32 AM CST
SHE:300463 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -56.49 | -41.49 | 126.81 | 312.62 | 708.18 | 956.6 |
Depreciation & Amortization | 368.79 | 368.79 | 334.2 | 313.08 | 270.2 | 236.2 |
Other Amortization | 2.14 | 2.14 | 5.08 | 4.74 | 4.21 | 3.15 |
Loss (Gain) From Sale of Assets | 2.31 | 2.31 | 6.73 | 4.17 | 4.12 | 4.05 |
Asset Writedown & Restructuring Costs | 82.33 | 82.33 | 36.54 | 9.54 | 22.46 | 26.01 |
Loss (Gain) From Sale of Investments | 0.27 | 0.27 | -5.03 | -1.52 | -3.04 | -0.39 |
Provision & Write-off of Bad Debts | - | - | -9.92 | 38.27 | 36.26 | 7.76 |
Other Operating Activities | 175.3 | 67.67 | 114.91 | 80.63 | 45.15 | 126.85 |
Change in Accounts Receivable | 202.63 | 202.63 | 127.87 | 214.66 | -277.51 | 257.65 |
Change in Inventory | 28.39 | 28.39 | -0.8 | 11.09 | 15.21 | -19.23 |
Change in Accounts Payable | -11.73 | -11.73 | -77.74 | -51.46 | 47.91 | -45.96 |
Operating Cash Flow | 694.96 | 602.33 | 633.8 | 901.51 | 843.22 | 1,617 |
Operating Cash Flow Growth | 1.53% | -4.96% | -29.70% | 6.91% | -47.84% | 47.77% |
Capital Expenditures | -701.03 | -749.07 | -963.02 | -877.9 | -987.74 | -601.78 |
Sale of Property, Plant & Equipment | 29.16 | 27.67 | 20.81 | 18.18 | 20.25 | 1.95 |
Cash Acquisitions | - | - | - | - | -164.58 | - |
Divestitures | -5.64 | - | - | -8.69 | - | - |
Investment in Securities | -32.33 | 22.67 | 261.86 | 354.79 | -709.72 | -87.5 |
Other Investing Activities | -31.49 | -23.86 | 2.88 | 10.58 | 11.96 | 0.52 |
Investing Cash Flow | -741.32 | -722.59 | -677.47 | -503.04 | -1,830 | -686.81 |
Long-Term Debt Issued | - | 817.64 | 685.9 | 608.75 | 605.13 | 762.97 |
Long-Term Debt Repaid | - | -490.94 | -631.12 | -513.84 | -914.44 | -1,115 |
Net Debt Issued (Repaid) | 174.08 | 326.7 | 54.78 | 94.91 | -309.31 | -352.18 |
Issuance of Common Stock | - | - | - | - | 1,558 | - |
Repurchase of Common Stock | - | - | - | - | - | -175.43 |
Common Dividends Paid | -86.03 | -83.74 | -115.19 | -244.64 | -318.44 | -296.6 |
Other Financing Activities | -82.89 | -100.57 | -66.37 | -3.02 | -0.62 | -70.49 |
Financing Cash Flow | 5.16 | 142.39 | -126.78 | -152.75 | 930.05 | -894.69 |
Foreign Exchange Rate Adjustments | -8.62 | -3.83 | 0.19 | 1.35 | 5.19 | -2.15 |
Net Cash Flow | -49.83 | 18.31 | -170.26 | 247.07 | -51.38 | 33.02 |
Free Cash Flow | -6.06 | -146.74 | -329.22 | 23.61 | -144.52 | 1,015 |
Free Cash Flow Growth | - | - | - | - | - | 71.23% |
Free Cash Flow Margin | -0.28% | -6.76% | -12.92% | 0.81% | -4.00% | 25.50% |
Free Cash Flow Per Share | -0.01 | -0.24 | -0.54 | 0.04 | -0.24 | 1.82 |
Cash Income Tax Paid | 156.98 | 217.48 | 160.83 | 137.38 | 311.46 | 412.06 |
Levered Free Cash Flow | 117.75 | -42.79 | -208.04 | -54.49 | -410.11 | 404.7 |
Unlevered Free Cash Flow | 118.04 | -42.79 | -194.21 | -33.53 | -388.2 | 441.75 |
Change in Working Capital | 120.32 | 120.32 | 24.48 | 139.98 | -244.32 | 256.45 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.